Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,01 USD | +21,91% | +72,46% | +40,30% |
26/03 | SUTRO BIOPHARMA, INC. : Wedbush handhaaft koopadvies | ZM |
25/03 | Sutro Biopharma, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 302
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 14-01-09 |
Jane Chung
PSD | President | 53 | 09-08-21 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 31-01-13 |
Henry Heinsohn
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Borgman
CTO | Chief Tech/Sci/R&D Officer | 56 | 28-02-23 |
Shabbir Anik
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-05-16 |
Chief Tech/Sci/R&D Officer | - | 18-09-23 | |
Steve Michel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-20 |
Annie Chang
IRC | Investor Relations Contact | - | 18-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 24-06-19 |
James Panek
BRD | Director/Board Member | 71 | 07-01-20 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
John Freund
BRD | Director/Board Member | 70 | 01-02-14 |
Joseph Lobacki
BRD | Director/Board Member | 65 | 01-02-17 |
William Newell
CEO | Chief Executive Officer | 66 | 14-01-09 |
Michael Dybbs
BRD | Director/Board Member | 49 | 25-07-18 |
Heidi Hunter
BRD | Director/Board Member | 66 | 19-11-21 |
Jon Wigginton
BRD | Director/Board Member | 62 | 30-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 62 441 963 | 61 723 167 ( 98,85 %) | 0 | 98,85 % |
Bedrijfsgegevens
Sutro Biopharma, Inc.
111 Oyster Point Boulevard
94080, South San Francisco
+650 881 6500
http://www.sutrobio.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,30% | 308 mln. | |
+3,05% | 108 mld. | |
+9,91% | 104 mld. | |
+6,38% | 23,66 mld. | |
-11,72% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,11% | 16,19 mld. | |
+4,64% | 13,72 mld. | |
+34,80% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Sutro Biopharma, Inc. - Nasdaq
- Onderneming Sutro Biopharma, Inc.